Northwestern Memorial Foundation
Loyola University Medical Center
Advocate Children’s Ronald McDonald House
University of Chicago Cancer Research Center
Cancer Research Center of Hawaii
Hope Children’s Hospital
University of Chicago Hospitals
Dr. Michele Carbone
Little Company of Mary Hospital
Cancer Institute of New Jersey
American Cancer Society
Anderson Cancer Center
American Cancer Society from 1989 - 1997.
University of Chicago in 1999, 2003, 2004, 2005, 2006, 2008,2009,
& 2010 for the innovative research in the areas of prostate cancer, lung
cancer, pancreatic cancer, leukemia and Rhabdomyosarcoma (the most common form of
childhood sarcoma or skeletal muscle cancer).
Children's Hospital in 1998, 2000 & 2004 for the
implementation of peripheral stem cell transplantation programs, the
building of an outpatient cancer treatment center for children and
the establishment of long-term follow-up care for survivors of
Little company of
Mary Hospital in 2002 for the installation of an IMRT (Intensity
Modulated Radiation Therapy) system .
Cancer Institute of
New Jersey for research into the role of protein in the spread
of cancer .
Loyola University in
2001, 2003, 2005, 2007, 2008, 2009, & 2010 for cutting edge research in the
area of mesothelioma, which is associated with the exposure to
asbestos, to examine the role of diphtheria toxin called
Denileukin diftitox (ontak) in patients with metastasis pancreatic
cancer and researching non-smoker type small cell lung cancer .
Clinic in Minnesota in 2006, 2007, 2008, 2009, & 2010 for a germ therapy
study as an alternative for prostate cancer patients who have
exhausted all other treatments and further apply recent advances in
genomics and protemomics research in the efforts to find a cure for
and for expansion of the clinics' RLIMS database to include
pre-existing and pancreatic cancer tissue samples in the RLIMS
Cancer Research Center of Hawaii in 2006, 2008, 2009, & 2010
research of mesothelioma by Dr. Carbone and Dr. Haining Yang .
Northwestern Memorial Foundation in 2007 to
develop alternatives to chemotherapy for cancer treatment.
ARAMEC in 2007 to assist Dr. Carbone in his
research for mesothelioma.